HLA-DRB1 AS A PREDICTOR OF SURVIVAL IN IRAQI COVID-19 PATIENTS
Downloads
Objective: This study aimed to show some of the commensal species in the parts of the digestive system and their role in developing the immune system and other functions and their positive effect on the health of the host. Method: Molecular investigations have shown the presence of single, if not dozens of trillions of species, nutrients, and host cells. Results: The commensal bacteria in the digestive system play an important role in modifying and developing the immune system, as they provide environmental requirements of nutrients that protect the mucosal lining of the intestine, which in turn is affected by mutual interactions with the microbes of the digestive system. Novelty: Thus, the digestive system is considered one of the most complex systems due to the continuous interaction between the enormous number of microorganisms.
C.-C. Lai, T.-P. Shih, W.-C. Ko, H.-J. Tang, and P.-R. Hsueh, “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges,” Int. J. Antimicrob. Agents, vol. 55, no. 3, p. 105924, 2020.
A. A. Anjorin, “The coronavirus disease 2019 (COVID-19) pandemic: A review and an update on cases in Africa,” Asian Pac. J. Trop. Med., vol. 13, no. 5, pp. 199–203, 2020.
G.-U. Kim et al., “Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19,” Clin. Microbiol. Infect., vol. 26, no. 7, pp. 948.e1--948.e3, 2020.
T. Mokhtari, F. Hassani, N. Ghaffari, B. Ebrahimi, A. Yarahmadi, and G. Hassanzadeh, “COVID-19 and multiorgan failure: A narrative review on potential mechanisms,” J. Mol. Histol., vol. 51, no. 6, pp. 613–628, 2020.
C. I. van der Made, M. G. Netea, F. L. van der Veerdonk, and A. Hoischen, “Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19,” Genome Med., vol. 14, no. 1, p. 96, 2022.
S. Mocci et al., “A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G,” Front. Immunol., vol. 14, p. 1138559, 2023.
M.-T. Arango et al., “HLA-DRB1 the notorious gene in the mosaic of autoimmunity,” Immunol. Res., vol. 65, no. 1, pp. 82–98, 2017.
N. Lauterbach, “HLA-DP and HLA-E: targets for transplantation immunity,” Transplant. Rev., 2014.
N. B. Crux and S. Elahi, “Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections?,” Front. Immunol., vol. 8, p. 832, 2017.
D. Wolday et al., “HLA variation and SARS-CoV-2 specific antibody response,” Viruses, vol. 15, no. 4, p. 906, 2023.
S. D. Alden, “Genetic Structure of the Iraqi Population at 15 STRs and the Consequent Forensic Applications,” University of Kansas, 2017.
S. M. Jabbar and N. A. Al-Rashedi, “Mitochondrial DNA control region variation in an Iraqi population sample,” Int. J. Legal Med., vol. 135, no. 2, pp. 421–425, 2021.
S. M. Jabbar and N. A. Al-Rashedi, “Mitochondrial DNA control region variation in an Iraqi population sample,” Int. J. Legal Med., vol. 135, pp. 421–425, 2021.
N. A. Mawlood and R. K. Lafta, “Trends in COVID-19: Incidence, mortality, and case fatality in Iraq,” Saudi Med. J., vol. 43, no. 5, p. 500, 2022.
A. Ortolan, M. Lorenzin, M. Felicetti, A. Doria, and R. Ramonda, “Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis,” Int. J. Infect. Dis., vol. 99, pp. 496–504, 2020.
T. Takahashi et al., “Sex differences in immune responses that underlie COVID-19 disease outcomes,” Nature, vol. 588, no. 7837, pp. 315–320, 2020.
G. M. Bwire, “Coronavirus: why men are more vulnerable to Covid-19 than women?,” SN Compr. Clin. Med., vol. 2, no. 7, pp. 874–876, 2020.
S. H. Kim and Y. S. Jang, “Recent Insights into Cellular Crosstalk in Respiratory and Gastrointestinal Mucosal Immune Systems,” NCBI, 2020.
M. A. Barek, M. A. Aziz, and M. S. Islam, “Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases,” Heliyon, vol. 6, no. 12, 2020.
N. T. P. Lan et al., “Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection,” PLoS Negl. Trop. Dis., vol. 2, no. 10, p. e304, 2008.
M. Fernández-Mestre, C. V Navarrete, J. Brown, C. Brown, E. Correa, and Z. Layrisse, “HLA alleles and dengue virus infection in Venezuelan patients: a preliminary study,” Inmunología, vol. 28, no. 2, pp. 96–100, 2009.
S. E. Jamieson, H. Cordell, E. Petersen, R. McLeod, R. E. Gilbert, and J. M. Blackwell, “Host genetic and epigenetic factors in toxoplasmosis,” Mem. Inst. Oswaldo Cruz, vol. 104, pp. 162–169, 2009.
Copyright (c) 2025 Saif M. Ibrahim
This work is licensed under a Creative Commons Attribution 4.0 International License.
